214 related articles for article (PubMed ID: 16291812)
1. B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions.
Voswinkel J; Mueller A; Kraemer JA; Lamprecht P; Herlyn K; Holl-Ulrich K; Feller AC; Pitann S; Gause A; Gross WL
Ann Rheum Dis; 2006 Jul; 65(7):859-64. PubMed ID: 16291812
[TBL] [Abstract][Full Text] [Related]
2. [B lymphocyte differentiation in granulomatous tissues of the lung and the nasal mucosa in Wegener's granulomatosis: origin of anti-neutrophil cytoplasmic antibody formation?].
Krämer JA; Müller A; Herlyn K; Pitann S; Lamprecht P; Holl-Ulrich K; Feller AC; Gross WL; Gause A; Voswinkel J
Z Rheumatol; 2007 Sep; 66(5):421-9. PubMed ID: 17516076
[TBL] [Abstract][Full Text] [Related]
3. Single cell analysis of B lymphocytes from Wegener's granulomatosis: B cell receptors display affinity maturation within the granulomatous lesions.
Voswinkel J; Assmann G; Held G; Pitann S; Gross WL; Holl-Ulrich K; Herlyn K; Mueller A
Clin Exp Immunol; 2008 Dec; 154(3):339-45. PubMed ID: 18826496
[TBL] [Abstract][Full Text] [Related]
4. Is PR3-ANCA formation initiated in Wegener's granulomatosis lesions? Granulomas as potential lymphoid tissue maintaining autoantibody production.
Voswinkel J; Müller A; Lamprecht P
Ann N Y Acad Sci; 2005 Jun; 1051():12-9. PubMed ID: 16126940
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
Russell KA; Fass DN; Specks U
Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of Wegener's granulomatosis.
Gross WL; Trabandt A; Csernok E
Ann Med Interne (Paris); 1998 Sep; 149(5):280-6. PubMed ID: 9791561
[TBL] [Abstract][Full Text] [Related]
7. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study.
Csernok E; Holle J; Hellmich B; Willem J; Tervaert C; Kallenberg CG; Limburg PC; Niles J; Pan G; Specks U; Westman K; Wieslander J; De Groot K; Gross WL
Rheumatology (Oxford); 2004 Feb; 43(2):174-80. PubMed ID: 14585921
[TBL] [Abstract][Full Text] [Related]
9. Renal histology in Chinese patients with anti-myeloperoxidase autoantibody-positive Wegener's granulomatosis.
Chen M; Yu F; Wang SX; Zou WZ; Zhang Y; Zhao MH; Wang HY
Nephrol Dial Transplant; 2007 Jan; 22(1):139-45. PubMed ID: 16980322
[TBL] [Abstract][Full Text] [Related]
10. Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission.
Abdulahad WH; Stegeman CA; Limburg PC; Kallenberg CG
Arthritis Rheum; 2008 Jul; 58(7):2196-205. PubMed ID: 18576340
[TBL] [Abstract][Full Text] [Related]
11. Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen.
Reiners KS; Hansen HP; Krüssmann A; Schön G; Csernok E; Gross WL; Engert A; Von Strandmann EP
Immunology; 2004 Jun; 112(2):228-36. PubMed ID: 15147566
[TBL] [Abstract][Full Text] [Related]
12. Wegener's granulomatosis.
Lamprecht P; Gross WL
Herz; 2004 Feb; 29(1):47-56. PubMed ID: 14968341
[TBL] [Abstract][Full Text] [Related]
13. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG).
Brouwer E; Stegeman CA; Huitema MG; Limburg PC; Kallenberg CG
Clin Exp Immunol; 1994 Dec; 98(3):448-53. PubMed ID: 7994909
[TBL] [Abstract][Full Text] [Related]
14. Anti-proteinase 3 antibody activation of neutrophils can be inhibited by alpha1-antitrypsin.
Rooney CP; Taggart C; Coakley R; McElvaney NG; O'Neill SJ
Am J Respir Cell Mol Biol; 2001 Jun; 24(6):747-54. PubMed ID: 11415941
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of PR3-ANCA associated vasculitis.
Kallenberg CG
J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
[TBL] [Abstract][Full Text] [Related]
16. Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis.
Muller Kobold AC; Kallenberg CG; Tervaert JW
Br J Rheumatol; 1998 Aug; 37(8):901-7. PubMed ID: 9734683
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous manifestations of Wegener's granulomatosis: a clinicopathologic study of 17 patients and correlation to antineutrophil cytoplasmic antibody status.
Comfere NI; Macaron NC; Gibson LE
J Cutan Pathol; 2007 Oct; 34(10):739-47. PubMed ID: 17880578
[TBL] [Abstract][Full Text] [Related]
18. ANCA-associated vasculitis with renal involvement: an outcome analysis.
Weidner S; Geuss S; Hafezi-Rachti S; Wonka A; Rupprecht HD
Nephrol Dial Transplant; 2004 Jun; 19(6):1403-11. PubMed ID: 15069175
[TBL] [Abstract][Full Text] [Related]
19. Structural analysis of human antibodies to proteinase 3 from patients with Wegener granulomatosis.
Sibilia J; Benlagha K; Vanhille P; Ronco P; Brouet JC; Mariette X
J Immunol; 1997 Jul; 159(2):712-9. PubMed ID: 9218586
[TBL] [Abstract][Full Text] [Related]
20. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides.
Van Der Geld YM; Simpelaar A; Van Der Zee R; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG
Kidney Int; 2001 Jan; 59(1):147-59. PubMed ID: 11135067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
